{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:32:59Z","timestamp":1779409979600,"version":"3.53.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02390-3","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:15:16Z","timestamp":1779387316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional characterisation of dura mater \u03b1CGRP degradation fragments at vascular, immune, and CGRP receptor targets"],"prefix":"10.1186","volume":"27","author":[{"given":"Mette N.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens B.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip V.","family":"Reducha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M. L.","family":"Nordahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian A.","family":"Haanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2390_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23:34","journal-title":"J Headache Pain"},{"key":"2390_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41582-022-00763-1","volume":"19","author":"TJ Steiner","year":"2023","unstructured":"Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19:109\u2013117","journal-title":"Nat Rev Neurol"},{"key":"2390_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S1474-4422(25)00402-8","volume":"24","author":"GBDH Collaborators","year":"2025","unstructured":"Collaborators GBDH (2025) Global, regional, and national burden of headache disorders, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol 24:1005\u20131015","journal-title":"Lancet Neurol"},{"key":"2390_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBDH Collaborators","year":"2018","unstructured":"Collaborators GBDH (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:954\u2013976","journal-title":"Lancet Neurol"},{"key":"2390_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 97:553\u2013622","journal-title":"Physiol Rev"},{"key":"2390_CR6","doi-asserted-by":"publisher","first-page":"111557","DOI":"10.1016\/j.biopha.2021.111557","volume":"139","author":"J Khan","year":"2021","unstructured":"Khan J, Asoom LIA, Sunni AA, Rafique N, Latif R, Saif SA, Almandil NB, Almohazey D, AbdulAzeez S, Borgio JF (2021) Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother 139:111557","journal-title":"Biomed Pharmacother"},{"key":"2390_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804","journal-title":"Lancet Neurol"},{"key":"2390_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","volume":"19","author":"A May","year":"1999","unstructured":"May A, Goadsby PJ (1999) The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19:115\u2013127","journal-title":"J Cereb Blood Flow Metab"},{"key":"2390_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-021-01229-3","volume":"22","author":"E Spekker","year":"2021","unstructured":"Spekker E, Laborc KF, Bohar Z, Nagy-Grocz G, Fejes-Szabo A, Szucs M, Vecsei L, Pardutz A (2021) Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid. J Headache Pain 22:17","journal-title":"J Headache Pain"},{"key":"2390_CR10","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1096\/fba.2024-00188","volume":"7","author":"CT Morgan","year":"2025","unstructured":"Morgan CT, Nkadimeng SM (2025) The Role of Inflammation in Migraine Headaches: A Review. FASEB Bioadv 7:e70033","journal-title":"FASEB Bioadv"},{"key":"2390_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.npep.2017.02.080","volume":"64","author":"M Dux","year":"2017","unstructured":"Dux M, Will C, Eberhardt M, Fischer MJM, Messlinger K (2017) Stimulation of rat cranial dura mater with potassium chloride causes CGRP release into the cerebrospinal fluid and increases medullary blood flow. Neuropeptides 64:61\u201368","journal-title":"Neuropeptides"},{"key":"2390_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-neuro-080422-105509","volume":"46","author":"D Levy","year":"2023","unstructured":"Levy D, Moskowitz MA (2023) Meningeal Mechanisms and the Migraine Connection. Annu Rev Neurosci 46:39\u201358","journal-title":"Annu Rev Neurosci"},{"key":"2390_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14:338\u2013350","journal-title":"Nat Rev Neurol"},{"key":"2390_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"TW Ho","year":"2010","unstructured":"Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6:573\u2013582","journal-title":"Nat Rev Neurol"},{"key":"2390_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10194-024-01945-6","volume":"26","author":"SL Waever","year":"2025","unstructured":"Waever SL, Haanes KA (2025) Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: betaCGRP is translated but, unlike alphaCGRP, not sorted into axons. J Headache Pain 26:11","journal-title":"J Headache Pain"},{"key":"2390_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s10194-025-02072-6","volume":"26","author":"IM Christiansen","year":"2025","unstructured":"Christiansen IM, Reducha PV, Edvinsson L, Holm A, Haanes KA (2025) Ex vivo stimulation of the trigeminal nucleus caudalis induces peripheral CGRP release in the trigeminal ganglion and reveals a distinct dopamine-endocannabinoid mechanism relevant to migraine. J Headache Pain 26:141","journal-title":"J Headache Pain"},{"key":"2390_CR17","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, Hay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103:1565\u20131644","journal-title":"Physiol Rev"},{"key":"2390_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-024-01753-y","volume":"25","author":"R Oliveira","year":"2024","unstructured":"Oliveira R, Gil-Gouveia R, Puledda F (2024) CGRP-targeted medication in chronic migraine - systematic review. J Headache Pain 25:51","journal-title":"J Headache Pain"},{"key":"2390_CR19","doi-asserted-by":"crossref","unstructured":"Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre (1985) I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54\u201356","DOI":"10.1038\/313054a0"},{"key":"2390_CR20","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/head.15011","volume":"65","author":"ML Garelja","year":"2025","unstructured":"Garelja ML, Rees TA, Hay DL (2025) Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays. Headache 65:1744\u20131753","journal-title":"Headache"},{"key":"2390_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10194-024-01769-4","volume":"25","author":"G Garate","year":"2024","unstructured":"Garate G, Pascual J, Pascual-Mato M, Madera J, Martin MM, Gonzalez-Quintanilla V (2024) Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience. J Headache Pain 25:69","journal-title":"J Headache Pain"},{"key":"2390_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","volume":"30","author":"JM Hansen","year":"2010","unstructured":"Hansen JM, Hauge AW, Olesen J, Ashina M (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30:1179\u20131186","journal-title":"Cephalalgia"},{"key":"2390_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0333102416684344","volume":"38","author":"H Ashina","year":"2018","unstructured":"Ashina H, Schytz HW, Ashina M (2018) CGRP in human models of primary headaches. Cephalalgia 38:353\u2013360","journal-title":"Cephalalgia"},{"key":"2390_CR24","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(25)00109-6","volume":"405","author":"J Versijpt","year":"2025","unstructured":"Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A (2025) Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet 405:1014\u20131026","journal-title":"Lancet"},{"key":"2390_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s10194-022-01498-6","volume":"23","author":"P Barbanti","year":"2022","unstructured":"Barbanti P, Egeo G, Aurilia C, Altamura C, d\u2019Onofrio F, Finocchi C, Albanese M, Aguggia M, Rao R, Zucco M et al (2022) Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients. J Headache Pain 23:138","journal-title":"J Headache Pain"},{"key":"2390_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s10194-023-01698-8","volume":"24","author":"M Waliszewska-Prosol","year":"2023","unstructured":"Waliszewska-Prosol M, Vuralli D, Martelletti P (2023) What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants? J Headache Pain 24:163","journal-title":"J Headache Pain"},{"key":"2390_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0167-0115(85)90013-8","volume":"10","author":"ME Kraenzlin","year":"1985","unstructured":"Kraenzlin ME, Ch\u2019ng JL, Mulderry PK, Ghatei MA, Bloom SR (1985) Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones. Regul Pept 10:189\u2013197","journal-title":"Regul Pept"},{"key":"2390_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0167-0115(89)90176-6","volume":"25","author":"P Le Greves","year":"1989","unstructured":"Le Greves P, Nyberg F, Hokfelt T, Terenius L (1989) Calcitonin gene-related peptide is metabolized by an endopeptidase hydrolyzing substance P. Regul Pept 25:277\u2013286","journal-title":"Regul Pept"},{"key":"2390_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0014-2999(85)90706-X","volume":"115","author":"P Le Greves","year":"1985","unstructured":"Le Greves P, Nyberg F, Terenius L, Hokfelt T (1985) Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol 115:309\u2013311","journal-title":"Eur J Pharmacol"},{"key":"2390_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0143-4179(97)90014-7","volume":"31","author":"P Le Greves","year":"1997","unstructured":"Le Greves P, Andersson K, Silberring J (1997) Isolation and identification of CGRP C-terminal fragments in the rat spinal cord. Neuropeptides 31:19\u201323","journal-title":"Neuropeptides"},{"key":"2390_CR31","doi-asserted-by":"publisher","first-page":"8523","DOI":"10.1073\/pnas.1203195109","volume":"109","author":"YG Kim","year":"2012","unstructured":"Kim YG, Lone AM, Nolte WM, Saghatelian A (2012) Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides. Proc Natl Acad Sci U S A 109:8523\u20138527","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2390_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0022-3565(25)20247-6","volume":"258","author":"M Mimeault","year":"1991","unstructured":"Mimeault M, Fournier A, Dumont Y, St-Pierre S, Quirion R (1991) Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther 258:1084\u20131090","journal-title":"J Pharmacol Exp Ther"},{"key":"2390_CR33","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/s41598-024-84547-1","volume":"15","author":"JB Kristensen","year":"2025","unstructured":"Kristensen JB, Elster L, Lundh M, Ballarin-Gonzalez B, Alexopoulou F, Kraemer M, Jensen DM, Leurs U, Nielsen JC, Hansen HH et al (2025) Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment. Sci Rep 15:1870","journal-title":"Sci Rep"},{"key":"2390_CR34","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1210\/en.2003-1185","volume":"145","author":"WB Sneddon","year":"2004","unstructured":"Sneddon WB, Magyar CE, Willick GE, Syme CA, Galbiati F, Bisello A, Friedman PA (2004) Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments. Endocrinology 145:2815\u20132823","journal-title":"Endocrinology"},{"key":"2390_CR35","first-page":"677","volume":"8","author":"MW Taing","year":"2014","unstructured":"Taing MW, Rose FJ, Whitehead JP (2014) GLP-1(28\u201336)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly? Drug Des Devel Ther 8:677\u2013688","journal-title":"Drug Des Devel Ther"},{"key":"2390_CR36","doi-asserted-by":"publisher","first-page":"E1263","DOI":"10.1152\/ajpendo.00600.2012","volume":"304","author":"W Shao","year":"2013","unstructured":"Shao W, Wang Z, Ip W, Chiang YT, Xiong X, Chai T, Xu C, Wang Q, Jin T (2013) GLP-1(28\u201336) improves beta-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP\/PKA\/beta-catenin signaling in beta-cells in vitro. Am J Physiol Endocrinol Metab 304:E1263\u20131272","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2390_CR37","doi-asserted-by":"publisher","first-page":"E1118","DOI":"10.1152\/ajpendo.00576.2005","volume":"290","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Gethmann A, Nauck MA, Gotze O, Schmitz F, Deacon CF, Gallwitz B, Schmidt WE, Holst JJ (2006) The glucagon-like peptide-1 metabolite GLP-1-(9\u201336) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans. Am J Physiol Endocrinol Metab 290:E1118\u20131123","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2390_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.regpep.2011.01.003","volume":"167","author":"E Tomas","year":"2011","unstructured":"Tomas E, Stanojevic V, Habener JF (2011) GLP-1-derived nonapeptide GLP-1(28\u201336)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes. Regul Pept 167:177\u2013184","journal-title":"Regul Pept"},{"key":"2390_CR39","doi-asserted-by":"publisher","first-page":"C673","DOI":"10.1152\/ajpcell.00196.2012","volume":"304","author":"J Wang","year":"2013","unstructured":"Wang J, Haanes KA, Novak I (2013) Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium. Am J Physiol Cell Physiol 304:C673\u2013684","journal-title":"Am J Physiol Cell Physiol"},{"key":"2390_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/head.15082","volume":"66","author":"PV Reducha","year":"2026","unstructured":"Reducha PV, Nielsen LKS, Jensen MN, Edvinsson JCA, Kazantzi S, Waever SL, Lylloff T, Westgate CSJ, Edvinsson L, Haanes KA (2026) TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms. Headache 66:672\u2013687","journal-title":"Headache"},{"key":"2390_CR41","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1074\/mcp.RA120.002227","volume":"20","author":"LX Neves","year":"2021","unstructured":"Neves LX, Granato DC, Busso-Lopes AF, Carnielli CM, Patroni FMS, De Rossi T, Oliveira AK, Ribeiro ACP, Brandao TB, Rodrigues AN et al (2021) Peptidomics-Driven Strategy Reveals Peptides and Predicted Proteases Associated With Oral Cancer Prognosis. Mol Cell Proteom 20:100004","journal-title":"Mol Cell Proteom"},{"key":"2390_CR42","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11:2301\u20132319","journal-title":"Nat Protoc"},{"key":"2390_CR43","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.peptides.2005.11.014","volume":"27","author":"RJ Bailey","year":"2006","unstructured":"Bailey RJ, Hay DL (2006) Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27:1367\u20131375","journal-title":"Peptides"},{"key":"2390_CR44","doi-asserted-by":"publisher","first-page":"832589","DOI":"10.3389\/fphar.2022.832589","volume":"13","author":"A Jamaluddin","year":"2022","unstructured":"Jamaluddin A, Chuang CL, Williams ET, Siow A, Yang SH, Harris PWR, Petersen J, Bower RL, Chand S, Brimble MA et al (2022) Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo. Front Pharmacol 13:832589","journal-title":"Front Pharmacol"},{"key":"2390_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bph.16218","volume":"181","author":"ML Garelja","year":"2024","unstructured":"Garelja ML, Alexander TI, Bennie A, Nimick M, Petersen J, Walker CS, Hay DL (2024) Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors. Br J Pharmacol 181:142\u2013161","journal-title":"Br J Pharmacol"},{"key":"2390_CR46","doi-asserted-by":"publisher","first-page":"117295","DOI":"10.1016\/j.bcp.2025.117295","volume":"242","author":"M Nimick","year":"2025","unstructured":"Nimick M, Alexander TI, Garelja ML, Walker CS, Banerjee P, Hay DL (2025) Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat, and mouse calcitonin family receptors in transfected cells. Biochem Pharmacol 242:117295","journal-title":"Biochem Pharmacol"},{"key":"2390_CR47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1476-5381.1991.tb12497.x","volume":"104","author":"SR Hughes","year":"1991","unstructured":"Hughes SR, Brain SD (1991) A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br J Pharmacol 104:738\u2013742","journal-title":"Br J Pharmacol"},{"key":"2390_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0333102417691762","volume":"38","author":"CS Walker","year":"2018","unstructured":"Walker CS, Raddant AC, Woolley MJ, Russo AF, Hay DL (2018) CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured. Cephalalgia 38:437\u2013451","journal-title":"Cephalalgia"},{"key":"2390_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.bjp.0707134","volume":"150","author":"L Edvinsson","year":"2007","unstructured":"Edvinsson L, Nilsson E, Jansen-Olesen I (2007) Inhibitory effect of BIBN4096BS, CGRP(8\u201337), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 150:633\u2013640","journal-title":"Br J Pharmacol"},{"key":"2390_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1021\/acsptsci.9b00083","volume":"3","author":"ML Garelja","year":"2020","unstructured":"Garelja ML, Au M, Brimble MA, Gingell JJ, Hendrikse ER, Lovell A, Prodan N, Sexton PM, Siow A, Walker CS et al (2020) Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors. ACS Pharmacol Transl Sci 3:246\u2013262","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2390_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1476-5381.2011.01717.x","volume":"166","author":"RJ Bailey","year":"2012","unstructured":"Bailey RJ, Walker CS, Ferner AH, Loomes KM, Prijic G, Halim A, Whiting L, Phillips AR, Hay DL (2012) Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes. Br J Pharmacol 166:151\u2013167","journal-title":"Br J Pharmacol"},{"key":"2390_CR52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1083\/jcb.200704053","volume":"179","author":"BE Padilla","year":"2007","unstructured":"Padilla BE, Cottrell GS, Roosterman D, Pikios S, Muller L, Steinhoff M, Bunnett NW (2007) Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins. J Cell Biol 179:981\u2013997","journal-title":"J Cell Biol"},{"key":"2390_CR53","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/BF00214011","volume":"251","author":"B Krisch","year":"1988","unstructured":"Krisch B (1988) Ultrastructure of the meninges at the site of penetration of veins through the dura mater, with particular reference to Pacchionian granulations. Investigations in the rat and two species of New-World monkeys (Cebus apella, Callitrix jacchus). Cell Tissue Res 251:621\u2013631","journal-title":"Cell Tissue Res"},{"key":"2390_CR54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF00221652","volume":"257","author":"DN Angelov","year":"1989","unstructured":"Angelov DN, Vasilev VA (1989) Morphogenesis of rat cranial meninges. A light- and electron-microscopic study. Cell Tissue Res 257:207\u2013216","journal-title":"Cell Tissue Res"},{"key":"2390_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-021-01320-9","volume":"22","author":"M Risch","year":"2021","unstructured":"Risch M, Vogler B, Dux M, Messlinger K (2021) CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater. J Headache Pain 22:105","journal-title":"J Headache Pain"},{"key":"2390_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0169-328X(95)00312-G","volume":"37","author":"R Ludwig","year":"1996","unstructured":"Ludwig R, Feindt J, Lucius R, Petersen A, Mentlein R (1996) Metabolism of neuropeptide Y and calcitonin gene-related peptide by cultivated neurons and glial cells. Brain Res Mol Brain Res 37:181\u2013191","journal-title":"Brain Res Mol Brain Res"},{"key":"2390_CR57","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/0006-2952(92)90498-8","volume":"43","author":"AF Walls","year":"1992","unstructured":"Walls AF, Brain SD, Desai A, Jose PJ, Hawkings E, Church MK, Williams TJ (1992) Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem Pharmacol 43:1243\u20131248","journal-title":"Biochem Pharmacol"},{"key":"2390_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1165\/ajrcmb\/3.1.27","volume":"3","author":"EK Tam","year":"1990","unstructured":"Tam EK, Caughey GH (1990) Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 3:27\u201332","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2390_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/acel.12428","volume":"15","author":"B Lyons","year":"2016","unstructured":"Lyons B, Kwan AH, Truscott RJ (2016) Spontaneous cleavage of proteins at serine and threonine is facilitated by zinc. Aging Cell 15:237\u2013244","journal-title":"Aging Cell"},{"key":"2390_CR60","doi-asserted-by":"publisher","first-page":"8686","DOI":"10.1074\/jbc.M115.713628","volume":"291","author":"SM Lee","year":"2016","unstructured":"Lee SM, Hay DL, Pioszak AA (2016) Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS. J Biol Chem 291:8686\u20138700","journal-title":"J Biol Chem"},{"key":"2390_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/164_2018_132","volume":"255","author":"J Simms","year":"2019","unstructured":"Simms J, Routledge S, Uddin R, Poyner D (2019) The Structure of the CGRP and Related Receptors. Handb Exp Pharmacol 255:23\u201336","journal-title":"Handb Exp Pharmacol"},{"key":"2390_CR62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1468-2982.2007.01321.x","volume":"27","author":"N Schwenger","year":"2007","unstructured":"Schwenger N, Dux M, de Col R, Carr R, Messlinger K (2007) Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 27:481\u2013491","journal-title":"Cephalalgia"},{"key":"2390_CR63","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","volume":"123","author":"M Kulka","year":"2008","unstructured":"Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123:398\u2013410","journal-title":"Immunology"},{"key":"2390_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2982.2004.00502.x","volume":"16","author":"SC Bischoff","year":"2004","unstructured":"Bischoff SC, Schwengberg S, Lorentz A, Manns MP, Bektas H, Sann H, Levi-Schaffer F, Shanahan F, Schemann M (2004) Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol Motil 16:185\u2013193","journal-title":"Neurogastroenterol Motil"},{"key":"2390_CR65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fncel.2019.00114","volume":"13","author":"SH Pedersen","year":"2019","unstructured":"Pedersen SH, la Cour SH, Calloe K, Hauser F, Olesen J, Klaerke DA, Jansen-Olesen I (2019) PACAP-38 and PACAP(6\u201338) Degranulate Rat Meningeal Mast Cells via the Orphan MrgB(3)-Receptor. Front Cell Neurosci 13:114","journal-title":"Front Cell Neurosci"},{"key":"2390_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s10194-024-01717-2","volume":"25","author":"N Friedrich","year":"2024","unstructured":"Friedrich N, Nemeth K, Tanner M, Rosta J, Dobos I, Oszlacs O, Jancso G, Messlinger K, Dux M (2024) Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat. J Headache Pain 25:9","journal-title":"J Headache Pain"},{"key":"2390_CR67","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1468-2982.1997.1703166.x","volume":"17","author":"A Ottosson","year":"1997","unstructured":"Ottosson A, Edvinsson L (1997) Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17:166\u2013174","journal-title":"Cephalalgia"},{"key":"2390_CR68","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1021\/acschembio.6b00616","volume":"11","author":"BM Manning","year":"2016","unstructured":"Manning BM, Gruba SM, Meyer AF, Haynes CL (2016) Neuropeptide-Induced Mast Cell Degranulation and Characterization of Signaling Modulation in Response to IgE Conditioning. ACS Chem Biol 11:3077\u20133083","journal-title":"ACS Chem Biol"},{"key":"2390_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2220\/biomedres.35.285","volume":"35","author":"JH Kim","year":"2014","unstructured":"Kim JH, Yamamoto T, Lee J, Yashiro T, Hamada T, Hayashi S, Kadowaki M (2014) CGRP, a neurotransmitter of enteric sensory neurons, contributes to the development of food allergy due to the augmentation of microtubule reorganization in mucosal mast cells. Biomed Res 35:285\u2013293","journal-title":"Biomed Res"},{"key":"2390_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0196-9781(98)00172-7","volume":"20","author":"Y Frobert","year":"1999","unstructured":"Frobert Y, Nevers MC, Amadesi S, Volland H, Brune P, Geppetti P, Grassi J, Creminon C (1999) A sensitive sandwich enzyme immunoassay for calcitonin gene-related peptide (CGRP): characterization and application. Peptides 20:275\u2013284","journal-title":"Peptides"},{"key":"2390_CR71","doi-asserted-by":"publisher","first-page":"11076","DOI":"10.1080\/21655979.2021.2006977","volume":"12","author":"L David","year":"2021","unstructured":"David L, Scalley-Kim M, Olland A, White A, Misura K (2021) The eptinezumab:CGRP complex structure - the role of conformational changes in binding stabilization. Bioengineered 12:11076\u201311086","journal-title":"Bioengineered"},{"key":"2390_CR72","doi-asserted-by":"crossref","unstructured":"Raffaelli B, Terhart M, Fitzek MP, Lange KS, Mecklenburg J, Overeem LH, Siebert A, Storch E, Reuter U (2023) Change of CGRP plasma concentrations in migraine after discontinuation of CGRP-(Receptor) monoclonal antibodies. Pharmaceutics 15","DOI":"10.3390\/pharmaceutics15010293"},{"key":"2390_CR73","doi-asserted-by":"publisher","first-page":"333102424128887","DOI":"10.1177\/03331024241288875","volume":"44","author":"P Triller","year":"2024","unstructured":"Triller P, Blessing VN, Overeem LH, Fitzek MP, Hong JB, Lange KS, Reuter U, Raffaelli B (2024) Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study. Cephalalgia 44:3331024241288875","journal-title":"Cephalalgia"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02390-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:02:48Z","timestamp":1779408168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02390-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2390"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02390-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with Directive 2010\/63\/EU, and the procedures were approved by the Danish Animal Experiments Inspectorate (license number 2025-25-0201-01469).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}